Compare Perdana Bangun Pusaka Tbk (KONI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Perdana Bangun Pusaka Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Perdana Bangun Pusaka Tbk trades at Rp2,070 (market cap 661.44B, 30.6K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Perdana Bangun Pusaka Tbk is far larger — about 6.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KONI | SCPI | |
|---|---|---|
Market Cap | 661.44B | 104.4B |
Volume | 30.6K | — |
Lot | 306 | — |
Turnover | 66.04M | — |
Average Price | 2,158.17 | — |
Value | 66.04M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Perdana Bangun Pusaka Tbk
PT. Perdana Bangun Persaka Tbk conducting business in the field of photography trade business and its equipment, and capital participation in its affiliates. The company is established in 1987 and registered at the Jakarta Stock Exchange since 1995 and a sole distributor of photography products produced by Konica Corporation, Japan. Product marketed by the company are as follows: KONICA color film and photography paper, KONICA photo printing machine, KONIKA X-ray film and chemicals for photography of KONICA trade mark.
Read more on KONI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
